Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
20.35    0.99 (5.11%)
Bid:
20.25
Ask:
20.35
Spread: 0.10 (0.494%)
Market Cap: £378.73m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

AGM Statement

31 May 2024 12:30

RNS Number : 6880Q
EnQuest PLC
31 May 2024
 

EnQuest PLC

 ("EnQuest" or the "Company")

 

Voting results of the Annual General Meeting held on 30 May 2024

 

EnQuest announces that at the Company's Annual General Meeting held yesterday, all resolutions set out in the Notice of Annual General Meeting and put to the meeting were passed by the requisite majority by way of a poll. The results of the poll are set out below:

 

Resolution

For *

%

Against

%

Withheld **

1

 

Annual Report

& Accounts 2023

965,836,187

99.99%

87,514

0.01%

10,646,415

2

 

Re-election of

Amjad Bseisu

965,446,297

98.87%

11,073,760

1.13%

50,059

3

 

Election of

Jonathan Copus

976,304,967

99.98%

243,635

0.02%

21,514

4

 

Re-election of Gareth Penny

934,699,932

95.71%

41,861,122

4.29%

9,062

5

 

Re-election Farina Khan

946,624,207

96.94%

29,924,394

3.06%

21,515

6

 

Election of Michael Borrell

976,307,326

99.98%

241,276

0.02%

21,514

7

 

Election of Rosalind Kainyah

976,291,060

99.97%

257,542

0.03%

21,514

8

Election of Marianne Daryabegui

976,194,811

99.96%

354,060

0.04%

21,245

9

Re-appointment of auditor

976,297,647

99.98%

216,900

0.02%

55,569

10

Authority to set auditor remuneration

976,391,276

99.98%

152,950

0.02%

25,890

11

Directors' Remuneration Report

831,425,573

85.31%

143,211,212

14.69%

1,933,331

12

Directors' Remuneration

Policy

951,492,134

97.44%

25,026,131

2.56%

51,851

13

Political Donations

965,165,774

99.91%

845,138

0.09%

10,559,204

14

Authority to allot shares

975,866,202

99.94%

610,667

0.06%

93,247

15***

Disapplication of pre-emption rights

952,323,439

97.53%

24,140,978

2.47%

105,699

16***

Further disapplication of pre-emption rights

899,997,664

92.17%

76,447,373

7.83%

125,079

17***

Authority to purchase own shares

965,889,305

98.91%

10,656,685

1.09%

24,126

18***

Authority to call general meeting not less than 14 days

960,920,627

98.40%

15,648,375

1.60%

1,114

 

* Includes discretionary votes

** A vote withheld is not a vote in law and is not counted for the purposes of the calculation of the proportion of votes 'For' or 'Against' a resolution

*** Indicates a Special Resolution

 

As at the record date for the Annual General Meeting, there were 1,915,924,339 Ordinary shares in issue. Based on the settlement dates of EnQuest's share buy back programme, which differs from the purchase date of any buy back, 4,038,069 Ordinary Shares were held in Treasury with total voting rights in the Company at the date of the AGM 1,911,886,270.

 

The full text of each resolution can be found in the Notice of Meeting which is available on the Company's website:

 https://www.enquest.com/investors/shareholder-information/annual-general-meetings

 

The Company will submit to the National Storage Mechanism copies of the Resolutions passed at the Annual General Meeting and these will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism

 

 

 

ENQUEST

EnQuest is providing creative solutions through the energy transition. As an independent energy company with operations in the UK North Sea and Malaysia, the Group's strategic vision is to be the partner of choice for the responsible management of existing energy assets, applying its core capabilities to create value through the transition.

 

EnQuest PLC trades on the London Stock Exchange.

 

Please visit our website www.enquest.com for more information on our global operations.

 

ENDS

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMFLFLLEDILVIS
Date   Source Headline
6th Dec 20227:00 amRNSChairman succession
24th Nov 20227:00 amRNSOperations Update
26th Oct 20227:00 amRNSSuccessful refinancing of capital structure
13th Oct 20227:00 amRNSPricing of new bond issue
16th Sep 20223:30 pmRNSDirector/PDMR
16th Sep 20223:00 pmRNSDirector/PDMR Shareholding
6th Sep 20227:00 amRNSHalf-year Report
30th Aug 20229:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSOperations Update
1st Aug 202212:33 pmRNSDirector/PDMR Shareholding
25th Jul 202210:28 amRNSDirector/PDMR Shareholding
22nd Jul 20222:46 pmRNSDirector/PDMR Shareholding
20th Jul 20222:04 pmRNSDirector/PDMR Shareholding
18th Jul 20224:11 pmRNSDirector/PDMR Shareholding
14th Jul 20224:46 pmRNSDirector/PDMR Shareholding
20th Jun 202210:33 amRNSDirector/PDMR Shareholding
17th Jun 20223:22 pmRNSAGM Statement
17th Jun 20227:00 amRNSBoard Change
15th Jun 202212:17 pmRNSDirector/PDMR Shareholding
14th Jun 20228:44 amRNSDirector/PDMR Shareholding
1st Jun 20224:57 pmRNSHolding(s) in Company
24th May 20224:42 pmRNSNotice of AGM
23rd May 20227:00 amRNSOperations update
29th Apr 20223:00 pmRNSReport on Payments to Govts
25th Apr 20223:38 pmRNSDirector/PDMR Shareholding
25th Apr 20223:00 pmRNSHolding(s) in Company
21st Apr 20227:00 amRNSIssue of Debt
14th Apr 20223:00 pmRNSHolding(s) in Company
11th Apr 20224:45 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSProspectus publication and launch of retail notes
30th Mar 20227:00 amRNSLaunch of exchange offer
24th Mar 20227:05 amRNSAnnual Financial Report
24th Mar 20227:01 amRNSResults for the year ended 31 December 2021
24th Mar 20227:00 amRNSDirectorate Change
15th Mar 20223:00 pmRNSHolding(s) in Company
11th Mar 20223:00 pmRNSHolding(s) in Company
10th Mar 20223:00 pmRNSHolding(s) in Company
2nd Mar 20223:00 pmRNSHolding(s) in Company
28th Feb 20223:00 pmRNSHolding(s) in Company
25th Feb 20223:00 pmRNSHolding(s) in Company
24th Feb 20223:00 pmRNSHolding(s) in Company
23rd Feb 20224:16 pmRNSHolding(s) in Company
17th Feb 20221:51 pmRNSHolding(s) in Company
16th Feb 20224:57 pmRNSHolding(s) in Company
15th Feb 20223:00 pmRNSHolding(s) in Company
11th Feb 202210:00 amRNSDirector/PDMR Shareholding
3rd Feb 20227:00 amRNSOperations update
7th Jan 20229:32 amRNSDirector/PDMR Shareholding
22nd Dec 20218:36 amRNSDirectorate Change
20th Dec 20213:56 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.